Neurovalens is a global health-tech company focused on developing non-invasive neurostimulation products to solve some of the world’s most significant health challenges. The company’s Modius technology is drug-free non-invasive, and influences the deep parts of the brain with a small and safe electrical pulse. The noninvasive approach removes the need for surgical implantation and allows much earlier intervention in the treatment pathway. Modius is currently available to US Veterans through the Department of Veterans Affairs (VA) Product Line: ● Modius Spero for PTSD (FDA Granted via De Novo) ● Modius Sleep for Insomnia (FDA Cleared via 510(k)) ● Modius Calm for Anxiety (FDA Cleared via 510(k))
Looking for a particular Neurovalens employee's phone or email?
The Neurovalens annual revenue was $7 million in 2026.
Jason McKeown is the CEO of Neurovalens.
19 people are employed at Neurovalens.
Neurovalens is based in Belfast, Northern Ireland.
The NAICS codes for Neurovalens are [5417, 541, 54].
The SIC codes for Neurovalens are [87, 873].